Kevin J. Croce, MD, PhD

Calcium Corner

03/04/2022

We have been using IVL in the coronary arteries since its approval last year and have had a very pleasant experience. IVL’s ability to change the compliance of calcified lesions has been very helpful.

We have been using IVL in the...

03/04/2022

Cath Lab Digest

Original Contribution

Practice Patterns in the Interventional Treatment of Coronary Bifurcation Lesions: A Global Survey

01/03/2022

M. Nicholas Burke , MD;

Kevin J. Croce , MD, PhD;

Yiannis S. Chatzizisis , MD, PhD;

Hani Jneid , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Lorenzo Azzalini , MD, PhD, MSc;

Brian A. Bergmark , MD;

Jason Wollmuth , MD;

Allison Hall , MD;

Judit Karacsonyi , MD, PhD;

Bavana V. Rangan , BDS, MPH, MD;

Evangelia Vemmou , MD;

Ilias Nikolakopoulos , MD;

The study aim was to assess current procedural strategies and perceptions for percutaneous coronary intervention (PCI) involving bifurcations.

The study aim was to assess...

01/03/2022

Journal of Invasive Cardiology

Original Research

A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention

10/13/2022

Santiago Garcia , MD;

Anastasios Milkas , MD, PhD;

Byeong-Keuk Kim , MD, PhD;

M. Nicholas Burke , MD;

Nidal Abi Rafeh , MD;

Jaikirshan J. Khatri , MD;

Lorenzo Azzalini , MD, PhD, MSc;

Kevin J. Croce , MD, PhD;

Michael S. Megaly , MD, MS;

Khaldoon Alaswad , MD;

Amirali Masoumi , MD;

Wissam A. Jaber , MD;

Kambis Mashayekhi , MD;

William J. Nicholson , MD;

Margaret B. McEntegart , MD, PhD, BSc(Hons), MBChB;

Andrea Gagnor , MD;

Seung-Whan Lee , MD, PhD;

Georgios Sianos , MD, PhD;

Scott A. Harding , MD, RT(R)(CV);

Dimitrios Karmpaliotis , MD, PhD;

Alexandre Avran , MD, PhD;

Yangsoo Jang , MD, PhD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Farouc A. Jaffer , MD, PhD;

Darshan Doshi , MD, MS;

Judit Karacsonyi , MD, PhD;

Etsuo Tsuchikane , MD, PhD;

Bahadir Simsek , MD;

Hsien-Li Kao , MD;

Bavana V. Rangan , BDS, MPH, MD;

Carlo Di Mario , MD, PhD, FESC, FACC, FRCP;

Spyridon Kostantinis , MD;

Roberto Garbo , MD;

Alfredo Ruggero Galassi , MD;

Paul Poommipanit , MD, FACC, FSCAI;

Khalid O. Tammam , MD, PhD;

Gerald S. Werner , MD, PhD;

Evangelia Vemmou , MD;

Masahisa Yamane , MD, PhD;

Eugene B. Wu , MD, DM;

Ilias Nikolakopoulos , MD;

Stéphane Rinfret , MD, SM;

Paul Knaapen , MD, PhD;

Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) can improve patient symptoms, but it remains controversial whether it impacts subsequent clinical outcomes.

Chronic total occlusion (CTO)...

10/13/2022

Journal of Invasive Cardiology

Brief Contribution

Adverse Events With Intravascular Lithotripsy After Peripheral and Off-Label Coronary Use: A Report From the FDA MAUDE Database

12/01/2021

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Subhash Banerjee , MD, FSCAI;

Yashasvi Chugh , MD;

Santiago Garcia , MD;

M. Nicholas Burke , MD;

Jaikirshan J. Khatri , MD;

Mehdi H. Shishehbor , DO, MPH, PhD;

Kevin J. Croce , MD, PhD;

Khaldoon Alaswad , MD;

Bilal Murad , MD;

Currently only the peripheral intravascular lithotripsy device is approved for use in the United States. We queried the United States FDA MAUDE database from January 1, 2016 to December 14, 2020 for all reports of adverse events and modes of...

Currently only the peripheral...

12/01/2021

Journal of Invasive Cardiology